Zydus Cadila Q2 net up four-fold on surge in US sales, strong show at home

Firm prunes net debt by 40% since March 2020; consolidated income up 13%

On the back of an 18 per cent growth in its US sales and 11 per cent growth in its India business, Cadila Healthcare Ltd. (Zydus Cadila) registered a 341.60 per cent jump in its consolidated profit after tax (PAT) for the quarter ended September 30, 2020. The company grew its net profit for Q2 of FY21 to Rs 473.4 crore from Rs 107.2 crore in corresponding Q2 of previous fiscal year 2019-20.

The company's consolidated total income increased by 13.37 per cent to stand at Rs 3,847.5 crore in the July-September quarter this year as compared to Rs 3,393.5 crore